莫西沙星联合花红片治疗急性盆腔炎的效果
2014-10-23姚子懿秦立国
姚子懿+秦立国
[摘要] 目的 探讨莫西沙星联合花红片治疗急性盆腔炎的效果。 方法 将218例诊断为急性盆腔炎的患者随机分为治疗组和对照组,对照组(109例)静脉滴注莫西沙星注射液0.4 g,1次/d,治疗组(109例)在对照组的基础上给予花红片治疗,4~5片,3次/d,观察两组的疗效。 结果 治疗组总有效率为97.25%,高于对照组的89.91%,差异有统计学意义(P<0.05)。治疗组和对照组的致病菌清除率分别为79.1%、63.5%,差异有统计学意义(P<0.05)。 结论 莫西沙星联合花红片治疗急性盆腔炎的临床效果较好,抗菌性强,值得临床推广应用。
[关键词] 急性盆腔炎;莫西沙星;花红片
[中图分类号] R711.33 [文献标识码] A [文章编号] 1674-4721(2014)09(c)-0075-03
Efficacy of moxifloxac combined with Huahong tablets in the treatment of acute pelvic inflammatory disease
YAO Zi-yi1 QIN Li-guo2▲
1.Department of Obstetrics and Gynecology,Maternal and Child Health Hospital of Xifeng County in Liaoning Province,Xifeng 112400,China;2.Tieling Health College in Liaoning Province,Tieling 112000,China
[Abstract] Objective To explore efficacy of moxifloxac combined with Huahong tablets in the treatment of acute pelvic inflammatory disease. Methods 218 cases diagnosed as acute pelvic inflammatory disease were randomly divided into treatment group and control group,intravenous moxifloxacin injection 0.4 g,1 time per day was used in control group(109 cases),on the basis of control group,Huahong tablets,4~5 tablets,3 times per day was used in treatment group(109 cases).The effect of two groups was observed. Results Total effective rate of treatment group(97.25%)was higher than that of control group(89.91%),with statistical difference(P<0.05).The bacteria clearance rate of treatment group and control group was 79.1% and 63.5% respectively,with statistical difference(P<0.05). Conclusion Moxifloxac combined with Huahong tablets in the treatment of acute pelvic inflammatory disease have better clinical effect and strong anti-bacterial activity.It is worthy of clinical promotion and application.
[Key words] Acute pelvic inflammatory disease;Moxifloxacin;Huahong tablets
盆腔炎性疾病(pelvic inflammatory disease,PID)是女性最常见的生殖系统疾病之一,好发于性活跃期的女性,由内源性或外源性致病因子诱发致病。主要病理类型有盆腔腹膜炎、子宫内膜炎、输卵管炎及卵巢囊肿等[1]。主要临床症状为腹胀、腹痛、寒战高热,体检可有子宫压痛、宫颈抬举痛,附件包块[2]、阴道充血及有脓性分泌物等。急性盆腔炎若救治不及时,可转归为慢性盆腔炎,亦可导致弥漫性腹膜炎、感染性休克、败血症等,甚至危及生命。据相关报道的流行病学显示,该病的发病率为5%~6%[3-5],且具有复发率高的特点[6]。为探讨不同药物的治疗效果,本文针对本院收治的218例急性盆腔炎患者进行相应的对照研究,观察其疗效。
1 资料与方法
1.1 一般资料
选取本院门诊2011年1月~2014年4月收治的218例急性盆腔炎患者,均符合急性盆腔炎诊断标准,年龄22~65岁,平均35.4;因宫腔术后感染者60例,因性传播疾病感染者37例,因下生殖道感染者84例,因经期卫生不佳感染者27例,因慢性盆腔炎急性发作者10例。随机将218例患者分为两组,治疗组109例,对照组109例,两组的年龄、病程等比较差异无统计学意义(P>0.05),具有可比性。……
